JDJun Dong

Jun Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jun Dong has a total of 187 co-authors. Here are the top co-authors by number of shared publications:

  • Hyun-Dong Chang

    Deutsches Rheuma-Forschungszentrum Berlin, Berlin, Germany

    9 shared publications
  • Andreas Radbruch

    Department of Cell Biology, Deutsches Rheuma-Forschungszentrum Berlin, Institute of the Leibniz Association, Berlin, Germany

    8 shared publications
  • Andreas Radbruch

    Deutsches RheumaForschungsZentrum Berlin, ein Leibniz Institut

    7 shared publications
  • Carsten Perka

    5 shared publications
  • Pawel Durek

    Department of Cell Biology, Deutsches Rheuma-Forschungszentrum Berlin, Institute of the Leibniz Association, Berlin, Germany

    5 shared publications
  • Simon Reinke

    Berlin-Brandenburg Center for Regenerative Therapies , Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin and Berlin Institute of Health, Berlin, Germany

    5 shared publications

Latest Publications

  • Open Access

    Cross-reactive tissue-resident memory T lymphocytes—concepts, evidence, and open questions

    by Hong Lei, Ying Sun, Weihua Gong, Jun Dong

    Background: Tissue-resident memory T (Trm) cells have emerged as a distinct lymphocyte lineage that provides rapid, frontline immune surveillance in peripheral tissues while also contributing to durable systemic immunity. A critical and evolving aspect of Trm cell biology is their inherent cross-reactivity—the ability of a single T cell receptor (TCR) to recognize and respond to multiple related or unrelated antigens beyond its primary target. Main body: This review synthesizes current knowledge on the dual roles of cross-reactive Trm cells, which can mediate broad protection against heterologous infections and cancers but may also precipitate or exacerbate autoimmune pathology. We first address the developmental origins, tissue-specific distribution (from barrier surfaces to internal organs, including the central nervous system and bone marrow niches), and key functions that define the Trm population. A central focus is placed on the mechanistic basis of TCR cross-reactivity, comparing and contrasting its regulation in circulating memory T cells versus Trm cells. We delve into how tissue-specific signals, particularly local cytokine milieus and epigenetic reprogramming such as demethylation imprints, shape the functional avidity and antigenic breadth of Trm cell responses. Finally, we discuss emerging therapeutic strategies designed to either harness the protective cross-reactivity of Trm cells for next-generation vaccines and immunotherapies or to restrain its detrimental potential in autoimmune and inflammatory diseases. Conclusions: Trm cells are powerful immune sentinels whose TCR cross-reactivity enables broad protection but also risks autoimmunity. Understanding these precise rules is key to developing Trm-based immunotherapies against cancer and infections while avoiding autoimmunity.


  • Open Access

    Polyfunctional varicella-zoster virus–reactive memory CD4+ T cells reside in human bone marrow

    by Zixu Wang, Simon Reinke, Yu Shen, Xiangyi Deng, Tobias Alexander, Anne Claußnitzer, Sebastian Hardt, Luis Becker, Koji Tokoyoda, Carsten Perka, et al.


  • Open Access

    Methylomes of human CD4 and CD8 memory T lymphocytes reveal tissue-specific epigenetic signatures for maintenance and recall function

    by Xiangyi Deng, Weijie Du, Gilles Gasparoni, Abdulrahman Salhab, Karl Nordström, Jinchan Li, Viktoria Wagner, Erping Zhang, Joachim Wachtlin, Juliane Bodo, et al.

    Adaptive immunity relies on antibodies and memory B and T cells, with memory T cells providing "reactive memory". These cells either circulate in the blood or remain as tissue-resident memory T cells, yet the epigenetic mechanisms underlying their recall function and maintenance are not well understood. Here, we present a comprehensive analysis of 56 reduced representation bisulfite sequencing (RRBS) datasets from 22 memory CD4 and CD8 T-cell populations isolated from human bone marrow, intestine, spleen, lung, skin, and peripheral blood, including surface CD69-positive and CD69-negative cells. Our study reveals unique DNA hypomethylation patterns in tissue-resident memory T cells, particularly in regions associated with genes involved in tissue homing, residency, and transcription factors regulating recall effector memory. The methylomes and differential methylation signatures identified here serve as a valuable resource for understanding the epigenetic program of memory T lymphocytes, their roles in immunological recall, and their maintenance within specific tissues. Graphical Abstract


  • Open Access

    Surface CD69‐Negative CD4 and CD8 Bone Marrow‐Resident Human Memory T Cells

    by Emilia Schneider Revueltas, Marta Ferreira‐Gomes, Gabriela Maria Guerra, Pawel Durek, Frederik Heinrich, Anna Casanovas Subirana, Koji Tokoyoda, Jun Dong, Simon Reinke, Sebastian Hardt, et al.

    Across tissues, tissue‐resident memory T cells have been defined as cells that express CD69 on their cell surface but not sphingosine‐1‐phosphate receptor 1 (S1PR1), the receptor for the tissue‐egress signal sphingosine‐1‐phosphate (S1P). It is less clear whether CD69‐negative memory T cells are also tissue‐resident. Here, we compare transcriptomes and T cell receptor repertoires of individual CD4 and CD8 memory T cells from paired blood and bone marrow samples from three human donors. CD69− memory T cells of blood and bone marrow share transcriptionally defined clusters, characterized by signature genes and reflecting their imprinting during original activation. However, cells of related clusters from blood and bone marrow have different TCR repertoires, evidence that they represent distinct compartments of memory and indicating that the CD69− memory T cells are residents of the bone marrow. Interestingly, the surface CD69− memory T cells of bone marrow do transcribe the CD69 gene and express S1PR1, suggesting that they are blindfolded to the perception of the egress signal sphingosine‐1‐phosphate by dimerization and internalization of CD69 and S1PR1, maintaining them in the bone marrow.


  • Open Access

    Rethinking ‘immunological memory’: Local and systemic immunity provided by bone marrow‐resident memory cells

    by Mairi Anne McGrath, Jun Dong, Mir‐Farzin Mashreghi, Hyun‐Dong Chang, Andreas Radbruch

    It has been 25 years since we first described long‐lived memory plasma cells of the bone marrow, 13 years since we identified bone marrow resident memory T cells and 2 years since we showed that the bone marrow is also a preferred location of resident memory B cells. The bone marrow is increasingly recognized as a fundamental component of long‐lasting immunological memory, not only providing protective immunity but also fuelling chronic inflammation. We now understand that the bone marrow functions as the ‘backbone’ of immunological memory, hosting the memory plasma cells which provide not only humoral immunity but also memory B and T cells, which constitute ‘reactive memory’. This knowledge now allows us to define true cellular ‘correlates of protection’ for systemic immunity, its quality and duration, as induced by infection and vaccination, something that has never been more important given the recent SARS‐CoV‐2 pandemic. While memory plasma cells of the bone marrow indicate long‐lasting humoral protection, memory T (and B) cells mobilized into the blood in secondary immune reactions indicate the strength of reactive memory. In this review, we have contextualized many of our own findings from the last two decades that have contributed to our understanding of how bone marrow‐resident memory cells provide local and systemic immunity.


  • Open Access

    A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4+ T lymphocytes in unexposed individuals

    by Jinchan Li, Simon Reinke, Yu Shen, Lena Schollmeyer, Yuk-Chien Liu, Zixu Wang, Sebastian Hardt, Christian Hipfl, Ute Hoffmann, Stefan Frischbutter, et al.

    Circulating, blood-borne SARS-CoV-2-reactive memory T cells in persons so far unexposed to SARS-CoV-2 or the vaccines have been described in 20-100% of the adult population. They are credited with determining the efficacy of the immune response in COVID-19. Here, we demonstrate the presence of preexisting memory CD4+ T cells reacting to peptides of the spike, membrane, or nucleocapsid proteins of SARS-CoV-2 in the bone marrow of all 17 persons investigated that had previously not been exposed to SARS-CoV-2 or one of the vaccines targeting it, with only 15 of these persons also having such cells detectable circulating in the blood. The preexisting SARS-CoV-2-reactive memory CD4+ T cells of the bone marrow are abundant and polyfunctional, with the phenotype of central memory T cells. They are tissue-resident, at least in those persons who do not have such cells in the blood, and about 30% of them express CD69. Bone marrow resident SARS-CoV-2-reactive memory CD4+ memory T cells are also abundant in vaccinated persons analyzed 10-168 days after 1°-4° vaccination. Apart from securing the bone marrow, preexisting cross-reactive memory CD4+ T cells may play an important role in shaping the systemic immune response to SARS-CoV-2 and the vaccines, and contribute essentially to the rapid establishment of long-lasting immunity provided by memory plasma cells, already upon primary infection.


  • Dysfunction of S100A4+ effector memory CD8+ T cells aggravates asthma

    by Huilei Zhang, Shuangqing Liu, Yanan Li, Jianru Li, Chen Ni, Ming Yang, Jun Dong, Zhaoqing Wang, Zhihai Qin

    Progressive loss of effector functions, especially IFN‐γ secreting capability, in effector memory CD8+ T (CD8+ TEM) cells plays a crucial role in asthma worsening. However, the mechanisms of CD8+ TEM cell dysfunction remain elusive. Here, we report that S100A4 drives CD8+ TEM cell dysfunction, impairing their protective memory response and promoting asthma worsening in an ovalbumin (OVA)‐induced asthmatic murine model. We find that CD8+ TEM cells contain two subsets based on S100A4 expression. S100A4+ subsets exhibit dysfunctional effector phenotypes with increased proliferative capability, whereas S100A4− subsets retain effector function but are more inclined to apoptosis, giving rise to a dysfunctional CD8+ TEM cell pool. Mechanistically, S100A4 upregulation of mitochondrial metabolism results in a decrease of acetyl‐CoA levels, which impair the transcription of effector genes, especially ifn‐γ, facilitating cell survival, tolerance, and memory potential. Our findings thus reveal general insights into how S100A4+ CD8+ TEM cells reprogram into dysfunctional and less protective phenotypes to aggravate asthma.


  • Open Access

    Resident memory CD4+ T lymphocytes mobilize from bone marrow to contribute to a systemic secondary immune reaction

    by Carla Cendón, Weijie Du, Pawel Durek, Yuk‐Chien Liu, Tobias Alexander, Lindsay Serene, Xinyi Yang, Gilles Gasparoni, Abdulrahman Salhab, Karl Nordström, et al.

    Resident memory T lymphocytes (TRM) of epithelial tissues and the Bm protect their host tissue. To what extent these cells are mobilized and contribute to systemic immune reactions is less clear. Here, we show that in secondary immune reactions to the measles‐mumps‐rubella (MMR) vaccine, CD4+ TRM are mobilized into the blood within 16 to 48 h after immunization in humans. This mobilization of TRM is cognate: TRM recognizing other antigens are not mobilized, unless they cross‐react with the vaccine. We also demonstrate through methylome analyses that TRM are mobilized from the Bm. These mobilized cells make significant contribution to the systemic immune reaction, as evidenced by their T‐cell receptor Vβ clonotypes represented among the newly generated circulating memory T‐cells, 14 days after vaccination. Thus, TRM of the Bm confer not only local, but also systemic immune memory.


  • Open Access

    Rapid Isolation of Functional ex vivo Human Skin Tissue-Resident Memory T Lymphocytes

    by Weijie Du, Daniel Lenz, Ralf Köhler, Erping Zhang, Carla Cendon, Jinchan Li, Mona Massoud, Joachim Wachtlin, Juliane Bodo, Anja E. Hauser, et al.

    Studies in animal models have shown that skin tissue-resident memory T (TRM) cells provide enhanced and immediate effector function at the site of infection. However, analyses of skin TRM cells in humans have been hindered by the lack of an optimized isolation protocol. Here, we present a combinatorial strategy-the 6-h collagenase IV digestion and gentle tissue dissociation – for rapid and efficient isolation of skin TRM cells with skin tissue-specific immune features. In comparison with paired blood circulating memory T cells, these ex vivo isolated skin T cells express typical TRM cell markers and display higher polyfunctional properties. Moreover, these isolated cells can also be assessed for longer periods of time in ex vivo cultures. Thus, the optimized isolation protocol provides a valuable tool for further understanding of human skin TRM cells, especially for direct comparison with peripheral blood T cells at the same sample collection time.


  • Open Access

    In severe COVID-19, SARS-CoV-2 induces a chronic, TGF-β-dominated adaptive immune response

    by Marta Ferreira-Gomes, Andrey Kruglov, Pawel Durek, Frederik Heinrich, Caroline Tizian, Gitta Anne Heinz, Anna Pascual-Reguant, Weijie Du, Ronja Mothes, Chaofan Fan, et al.

    Here we have analyzed the dynamics of the adaptive immune response triggered by SARS-CoV-2 in severely affected COVID-19 patients, as reflected by activated B cells egressing into the blood, at the single cell level. Early on, before seroconversion in response to SARS-CoV-2 spike protein, activated peripheral B cells displayed a type 1 interferon-induced gene expression signature. After seroconversion, activated B cells lost this signature, expressed IL-21- and TGF-β-induced gene expression signatures, and mostly IgG1 and IgA1. In the sustained immune reaction of the COVID-19 patients, until day 59, activated peripheral B cells shifted to expression of IgA2, reflecting instruction by TGF-β. Despite the continued generation of activated B cells, those cells were not found in the lungs of deceased COVID-19 patients, nor did the IgA2 bind to dominant antigens of SARS-CoV-2. In severe COVID-19, SARS-CoV-2 thus triggers a chronic immune reaction distracted from itself and instructed by TGF-β.